Sequenom genotyping and PNPLA3 sequencing were used to identify allele frequencies of the target SNPs within NAFLD cases, controls, and our sample Bronx population. The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.